Primary care electronic medication record discrepancies in patients starting treatment at a hospital- based ambulatory care pharmacy and impact on prevalence of potential drug--drug interactions.

Autor: González-Colominas, Elena, López Mula, Carlos, Martínez-Casanova, Javier, Luque, Sonia, Conde-Estévez, David, Monge-Escartín, Inés, Ferrández, Olivia

Publikováno v: European Journal of Hospital Pharmacy; Nov2023, Vol. 30 Issue 6, p333-339, 7p

Penetration of linezolid into the pleural cavity in critically ill patients with proven or suspected Gram-positive bacterial infections: a retrospective pharmacokinetic study.

Autor: De Antonio-Cuscó M; Pharmacy Department, Hospital del Mar, Barcelona, Spain., Sorlí L; Infectious Diseases Department, Hospital del Mar, Barcelona, Spain.; CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain.; Infectious Pathology and Antimicrobials Research Group (IPAR), Institut Hospital del Mar d' Investigacions Mèdiques (IMIM), Barcelona, Spain.; Universitat Pompeu Fabra (UPF), Barcelona, Spain., Muñoz-Bermúdez R; Critical Care Department, Hospital del Mar, Hospital del Mar, Spain.; Critical Illness Research Group (GREPAC), Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, Spain., López-Mula C; Pharmacy Department, Hospital Can Misses, Ibiza, Spain., Parrilla FJ; Critical Care Department, Hospital del Mar, Hospital del Mar, Spain.; Critical Illness Research Group (GREPAC), Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, Spain.; Universitat Pompeu Fabra (UPF), Barcelona, Spain., Gracia-Arnillas MP; Critical Care Department, Hospital del Mar, Hospital del Mar, Spain.; Critical Illness Research Group (GREPAC), Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, Spain.; Universitat Pompeu Fabra (UPF), Barcelona, Spain., Prim N; Laboratori de Referència de Catalunya, Department of Microbiology, Barcelona, Spain., Campillo Ambrós N; Pharmacy Department, Hospital del Mar, Barcelona, Spain., Horcajada JP; Infectious Diseases Department, Hospital del Mar, Barcelona, Spain.; Laboratori de Referència de Catalunya, Department of Microbiology, Barcelona, Spain.; Infectious Pathology and Antimicrobials Research Group (IPAR), Institut Hospital del Mar d' Investigacions Mèdiques (IMIM), Barcelona, Spain.; Universitat Pompeu Fabra (UPF), Barcelona, Spain., Masclans-Enviz JR; Critical Care Department, Hospital del Mar, Hospital del Mar, Spain.; Critical Illness Research Group (GREPAC), Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, Spain.; Universitat Pompeu Fabra (UPF), Barcelona, Spain., Grau S; Pharmacy Department, Hospital del Mar, Barcelona, Spain.; CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain.; Infectious Pathology and Antimicrobials Research Group (IPAR), Institut Hospital del Mar d' Investigacions Mèdiques (IMIM), Barcelona, Spain.; Universitat Pompeu Fabra (UPF), Barcelona, Spain., Luque S; Pharmacy Department, Hospital del Mar, Barcelona, Spain.; CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain.; Infectious Pathology and Antimicrobials Research Group (IPAR), Institut Hospital del Mar d' Investigacions Mèdiques (IMIM), Barcelona, Spain.

Publikováno v: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2024 Dec 26. Date of Electronic Publication: 2024 Dec 26.